CONGRESSES

Our medical oncologists and laboratory investigators are regular speakers and organizers of some of the most important international seminars and scientific meetings.

We have presented the results of our investigations into the causes of cancer and novel treatments at some of the most important national and international oncology congresses.

BROWSE CONGRESSES
BY YEAR

American Association for Cancer Research (AACR)

DATE16/04/2016 - 20/04/2016

PLACENew Orleans, USA

Comparison of nCounter, immunohistochemistry, RT-PCR and FISH to detect ALK, ROS1 and RET rearrangements and predict response to tyrosine kinase inhibitors in advanced non-small cell lung cancer (NSCLC) Cristina Teixidó, Noemí Reguart, Ana Giménez-Capitán, Miguel Ángel Molina, Patricia Galván, Sonia Rodríguez, Laia Paré, Santiago Viteri, Vicente Peg, Zaira Yeste, Nuria Viñolas, Rafael Rosell, Aleix Prat. Mini-Oral #4344

[return]
Large scale non-invasive screening of EGFR mutations in advanced NSCLC patients: Identify platform experience Clara Mayo de las Casas, Núria Jordana Ariza, Mónica Garzón Ibañez, Ariadna Balada Bel, Jordi Bertrán-Alamillo, Ana Pérez Rosado, Santiago Viteri Ramirez, Daniela Morales Espinosa, Juan Carlos Monasterio, Niki Karachaliou, Miguel Ángel Molina Vila, Rafael Rosell. Poster #3964

BRAF mutation analysis in cell free tumoral DNA (cfDNA) of melanoma patients: results from the prospective study GEM1304 (Spanish Melanoma Group) Maria Gonzalez Cao, Jose Luis Manzano, Virtudes Soriano, Teresa Puertolas, Ainara Soria, Clara Mayo, Margarita Magem, Miguel Angel Molina, Clara Montagut, Eva Muñoz, Delvys Rodriguez, Eva Perez, Almudena Garcia, Javier Cortes, Nuria Jordana, Jordi Rodon, Niki Karachaliou, Rafael Rosell. Poster #468

PB1, a DDR2 inhibitor with antitumor activity in preclinical models of squamous cell carcinoma and KRAS mutated adenocarcinoma of the lung Silvia García-Roman, Miguel Angel Molina, Jose Iñaki Borrell, Raimon Puig de la Bellacasa, Daniela Morales, Jordi Bertrán, Ana Gimenez-Capitán, Niki Karachaliou, Rafael Rosell. Poster #4802

Inhibition of epidermal growth factor receptor pathway by epidermal growth factor antibodies in non-small-cell lung cancer Jordi Codony-Servat, Miguel Angel Molina-Vila, Jordi Bertran-Alamillo, Eric d’Hondt, Rafael Rosell. Poster #2368

S49076, a kinase inhibitor of AXL, MET and FGFR with strong, selective preclinical activity against tumor cells with acquired resistance to EGFR inhibitors not carrying the T790M mutation Jordi Bertran-Alamillo, Miguel Angel Molina-Vila, Cristina Teixidó, Carles Codony-Servat, Jordi Codony-Servat, Rafael Rosell. Poster #336

XI European Lung Cancer Conference (ELCC)

DATE13/04/2016 - 16/04/2016

PLACEGeneva, Switzerland

Brigatinib Efficacy and Safety in Patients (Pts) With Anaplastic Lymphoma Kinase (ALK)–Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) in a Phase 1/2 Trial Rafael Rosell, Scott N Gettinger, Lyudmila A Bazhenova, Corey J Langer, Ravi Salgia, Alice T Shaw, Narayana I Narasimhan, David J Dorer, David Kerstein, D Ross Camidge. Oral. Abstract #233;133O

[return]
Paving the way for the next generation: a positive future for EGFRm NSCLC?
Rosell R. Oral. AstraZeneca Lung Cancer Scientific Meeting -Translating Science into Clinical Practice

An innovative co-targeting of signal transducer and activator of transcription 3 (STAT3) and Src-YAP pathways in EGFR mutant non-small cell lung cancer (NSCLC) Niki Karachaliou, Imane Chaib, Sara Pilotto, Jordi Codony, Xueting Cai, Xuefei Li, Silvia Marin, Caicun Zhou, Peng Cao, Rafael Rosell. Abstract #240. Poster 76P

The role of CTCs and cfDNA for diagnosis and monitoring of EGFR mutations in advanced NSCLC patients. Silvia Calabuig-Fariñas, Eloisa Jantus-Lewintre, Clara Mayo-de-las-Casas, Ana Blasco, Miguel A.Molina-Vila, Rafael Rosell, Carlos Camps. Abstract #445; Poster 149P

Molecular bases for combinatorial treatment strategies in KRAS mutant (KRASm) lung adenocarcinoma (LAC) Chiara Lazzari, Niki Karachaliou, Alberto Verlicchi, Imane Chaib, Silvia Marin, Anastasios Gkountakos, Sara Pilotto, Jose Luis Ramirez Serrano, Filippo de Marinis, Rafael Rosell. Abstract #257; Poster 63P

Differential expression profile of lung squamous cell carcinoma (LSCC) cell lines as a mean to predict drug interaction effects Alberto Verlicchi, Niki Karachaliou, Chiara Lazzari, Carles Codony Servat, Imane Chaib, Silvia Marin, Anastasios Gkountakos, Sara Pilotto, Jose Luis Ramirez Serrano, Rafael Rosell. Abstract #263; Poster 72P

IV Curso de Capacitación en Cáncer de Pulmón

DATE10/03/2016

PLACEAlcalá de Henares, Spain

Organized by the Spanish Lung Cancer Group (SLCG)

El Futuro de la Investigación en el Cáncer de Pulmón Rosell R, MD, PhD

37th Anual EORTC-PAMM Congress

DATE10/02/2016 - 12/02/2016

PLACEAntwep, Belgium

DNA repair and synthetic lethality Rosell R MD, PhD

27th International Congress on Anti-Cancer Treatment (ICACT)

DATE02/02/2016 - 04/08/2016

PLACEParis, France